Synprosis is specialized in solid phase manufacture of peptides for basic research and for therapeutic applications (cGMP). We can satisfy both the customer's needs from academic institution to major human or veterinary pharmaceutical companies.
Due to it's unique know-how, Synprosis can produce on a regular basis peptides of more than 100 Amino Acids in a short one-step process.
Synprosis offer custom peptide synthesis with high quality.

The founding mission of developing an anti-HIV1 vaccine based on the immunogenic activity of a particular protein of HIV1's variant TAT Oyi.
We propose a true expertise for your vaccine developments for infectiology as well as cancerology from the technical know-how developed through protein synthesis and medicinal pharmaceutical developments.

Specialized in peptide synthesis of long amino acid chains, SYNPROSIS uses advanced techniques developed through solid synthesis of Fast F moc type to serve your needs.
SYNPROSIS pays the utmost attention to the technical nature and quality of its work throughout the stages of synthesis, purification and analysis of the peptides
SYNPROSIS provides a complete range of service for therapeutical peptide production, from research needs to preclinical and clinical development (cGMP quality).

Our products are delivered as freeze-dried powder at 3 purity levels : 

· > 80%
· > 95%
· ultrapure peptides ( > 99%)
Quantities produced depend on the desired purity level and the length of required peptide.
 Common quantities vary from 1 to 15mg for > 30AA chains.
 Synprosis produces on a regular basis 100mg of 100AA ultrapure ( > 99% ) peptides (like HIV's TAT protein).

Besides the technical skills of SYNPROSIS, extent to the pharmaceutical development of medications. Its expertise in the field of vaccines can be applied in infectiology as well as in cancerology.